Publications by authors named "Bergeron E"

Reverse genetic systems are powerful tools in molecular virology that allow the generation of infectious recombinant virus and the manipulation of viral genomes. Reverse genetic systems enable the incorporation of reporter genes, facilitating many virological assays, including high-throughput screening. Additionally, reverse genetic systems can be used to introduce targeted mutations into the viral genome, allowing investigations of viral genetic elements and protein functions in virus pathogenesis and biology.

View Article and Find Full Text PDF

Advancement of vaccine candidates that demonstrate protective efficacy in screening studies necessitates detailed safety and immunogenicity investigations in pre-clinical models. A non-spreading Crimean-Congo hemorrhagic fever virus (CCHFV) viral replicon particle (VRP) vaccine was developed for single-dose administration to protect against disease. To date, several studies have supported safety, immunogenicity, and efficacy of the CCHF VRP in multiple highly sensitive murine models of lethal disease, but the VRP had yet to be evaluated in large animals.

View Article and Find Full Text PDF

Crimean-Congo haemorrhagic fever virus (CCHFV) causes human disease ranging from subclinical to a fatal haemorrhagic syndrome. Determinants of CCHF pathogenesis are largely unknown and animal models that recapitulate human disease are limited. A recently described mouse model uses a monoclonal antibody (mAb 5A3) targeting the interferon (IFN) alpha/beta receptor to suppress type I IFN responses, making animals transiently susceptible to infection.

View Article and Find Full Text PDF
Article Synopsis
  • - Pavlovian fear conditioning research has primarily focused on male rodents and the freezing response, but new findings reveal that female rodents exhibit a different response called "darting," characterized by rapid escape movements.
  • - Darting females (Darters) show less freezing than males and Non-darters, and they move faster when exposed to foot shocks, raising questions about the underlying mechanisms of these responses.
  • - Further investigation showed that Darters are not more sensitive to aversive stimuli compared to Non-darters and males; instead, they might be less reactive in certain cases, highlighting the need to consider individual responses in fear conditioning studies.
View Article and Find Full Text PDF
Article Synopsis
  • Ebola disease (EBOD) is a serious illness caused by viruses in the Orthoebolavirus genus, primarily the Ebola virus, posing challenges for public health due to its human-to-human transmission and limited treatment options.
  • Despite decades of research, the origins and detailed epidemiology of these viruses remain unclear, with serosurveys indicating higher infection rates than the observed clinical cases.
  • Recent work has mapped a specific B-cell epitope in the Ebola virus spike protein, revealing that cross-reactive antibodies provide insight into unexpected seroprevalences and suggest potential improvements in serological specificity for diagnosing EBOD.
View Article and Find Full Text PDF

Background: Pediatric cancer is associated with stressors that increase the risk for distress across family members. Psychosocial support varies and may not meet family needs and preferences. This study investigated family members' points of view regarding psychosocial service needs, as a first step of a large participative research project aiming to develop interventions grounded in key stakeholders' perspectives.

View Article and Find Full Text PDF

Pavlovian fear conditioning is a widely used tool that models associative learning in rodents. For decades the field has used predominantly male rodents and focused on a sole conditioned fear response: freezing. However, recent work from our lab and others has identified darting as a female-biased conditioned response, characterized by an escape-like movement across a fear conditioning chamber.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers developed a simple "mix-and-read" biosensor using a split NanoLuc luciferase to detect anti-NiV antibodies in samples, validated with over 700 serum samples from Bangladesh.
  • * The new biosensor showed high sensitivity (98.6%) and specificity (100%) compared to existing tests, though it is less effective for detecting antibodies shortly after symptoms begin, making it a valuable tool for NiV surveillance and outbreak investigations.
View Article and Find Full Text PDF

Immunizing mice with Crimean-Congo hemorrhagic fever virus (CCHFV) nucleoprotein (NP), glycoprotein precursor (GPC), or with the GP38 domain of GPC, can be protective when the proteins are delivered with viral vectors or as a DNA or RNA vaccine. Subunit vaccines are a safe and cost-effective alternative to some vaccine platforms, but Gc and Gn glycoprotein subunit vaccines for CCHFV fail to protect despite eliciting high levels of neutralizing antibodies. Here, we investigated humoral and cellular immune responses and the protective efficacy of recombinant NP, GP38, and GP38 forms (GP85 and GP160) associated with the highly glycosylated mucin-like (MLD) domain, as well as the NP + GP38 combination.

View Article and Find Full Text PDF

Background: Pneumatosis cystoides intestinalis (PCI), characterized by a collection of gas-filled cysts in the intestinal wall, is an uncommon but well-known condition in gastroenterology. Abdominal pain is the most frequent symptom associated with PCI. Intussusception represents a potential cause of recurrent abdominal pain or emergency presentation.

View Article and Find Full Text PDF
Article Synopsis
  • The rVSVΔG-ZEBOV-GP vaccine has been used during Ebola outbreaks, and a study in Uganda assessed healthcare workers' knowledge, attitudes, and long-term immune responses following vaccination.
  • Out of 565 surveyed healthcare workers, only 37% reported being vaccinated, and a significant portion lacked knowledge that the vaccine only protects against Ebola.
  • Despite the general desire for booster doses, the findings highlight the need for continued education on Ebola and other viral hemorrhagic fevers, especially since the vaccine's long-term effectiveness remains uncertain.
View Article and Find Full Text PDF
Article Synopsis
  • - Crimean-Congo hemorrhagic fever virus (CCHFV) is a dangerous pathogen that lacks effective vaccines, making it a priority for the WHO, and previous studies showed that a specific VRP vaccine can protect mice if given at least 3 days before exposure.
  • - Research indicates that non-specific immune responses are inadequate for immediate protection against CCHFV, as seen when Lassa virus VRP failed to protect mice prior to infection.
  • - Vaccination with CCHF VRP at varying times before exposure (28, 14, 7, or 3 days) effectively reduced viral levels and disease markers, with longer intervals leading to better outcomes, emphasizing the importance of antibody responses for effective protection.
View Article and Find Full Text PDF
Article Synopsis
  • CCHFV is a dangerous tick-borne virus with no approved treatments, and its L protein has a domain that interferes with immune responses, making it a potential drug target.
  • Researchers previously showed that a protein variant called CC4 can effectively inhibit CCHFV replication in lab settings.
  • In this study, they tested delivering CC4 using a modified adenovirus in mice, finding that while one injection method delivered the virus more effectively to the liver, it did not protect against lethal CCHFV infection.
View Article and Find Full Text PDF
Article Synopsis
  • * Norwaviruses and orthonairoviruses are notable as they can lead to febrile illnesses in humans, while some orthonairoviruses can cause varying degrees of disease severity in mammals, from mild to fatal.
  • * Nairovirids produce enveloped virions with one to three single-stranded RNA segments that code for essential proteins, including nucleoproteins and RNA polymerases necessary for their replication.
View Article and Find Full Text PDF

Deaf, deafblind, and hard of hearing (DDBHH) individuals experience barriers to accessing cancer screening, including ineffective patient-physician communication when discussing screening recommendations. For other underserved communities, culturally and linguistically aligned community health navigators (CHNs) have been shown to improve cancer screening and care. A needs assessment study was conducted to identify barriers and gather recommendations for CHN training resources.

View Article and Find Full Text PDF

Crimean-Congo hemorrhagic fever virus (CCHFV) is a WHO priority pathogen. Antibody-based medical countermeasures offer an important strategy to mitigate severe disease caused by CCHFV. Most efforts have focused on targeting the viral glycoproteins.

View Article and Find Full Text PDF

Nipah virus (NiV) is a highly pathogenic paramyxovirus. The Syrian hamster model recapitulates key features of human NiV disease and is a critical tool for evaluating antivirals and vaccines. Here we describe longitudinal humoral immune responses in NiV-infected Syrian hamsters.

View Article and Find Full Text PDF

Purpose Of Review: Optic neuritis can result from several distinct causes, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody disease (MOGAD), when not idiopathic. This review discusses evidence-based treatment approaches contingent upon each specific cause of optic neuritis.

Recent Findings: Current evidence highlights the need for prompt plasmapheresis as adjunct to intravenous methylprednisolone (IVMP) in patients with NMOSD-associated optic neuritis.

View Article and Find Full Text PDF

Ebola disease outbreaks are major public health events because of human-to-human transmission and high mortality. These outbreaks are most often caused by Ebola virus, but at least three related viruses can also cause the disease. In 2022, Sudan virus re-emerged causing more than 160 confirmed and probable cases.

View Article and Find Full Text PDF

Background: The recurrence of common bile duct stones and other biliary events after endoscopic retrograde cholangiopancreatography (ERCP) is frequent. Despite recommendations for early cholecystectomy, intervention during the same admission is carried out inconsistently.

Methods: We reviewed the records of patients who underwent ERCP for gallstone disease and common bile duct clearance followed by cholecystectomy between July 2012 and June 2022.

View Article and Find Full Text PDF

Background: Gallstone disease will affect 15% of the adult population with concomitant common bile duct stone (CBDS) occurring in up to 30%. Endoscopic retrograde cholangiopancreatography (ERCP) is the mainstay of management for removal of CBDS, as cholecystectomy for the prevention of recurrent biliary event (RBE). RBE occurs in up to 47% if cholecystectomy is not done.

View Article and Find Full Text PDF

Crimean-Congo hemorrhagic fever virus (CCHFV; family ) is a tick-borne pathogen that frequently causes lethal disease in humans. CCHFV has a wide geographic distribution, and cases have been reported in Africa, Asia, the Middle East, and Europe. Availability of a safe and efficacious vaccine is critical for restricting outbreaks and preventing disease in endemic countries.

View Article and Find Full Text PDF
Article Synopsis
  • In April 2023, the International Committee on Taxonomy of Viruses (ICTV) approved changes to the phylum's classification during their annual vote.
  • The update included the addition of one new family, 14 new genera, and 140 new species.
  • Additionally, the taxonomy featured the renaming of two genera and 538 species, along with the removal of one species and the abolition of four others.
View Article and Find Full Text PDF

Nipah virus (NiV) is a highly pathogenic paramyxovirus with a high case fatality rate. Due to its high pathogenicity, pandemic potential, and lack of therapeutics or approved vaccines, its study requires biosafety level 4 (BSL4) containment. In this report, we developed a novel neutralization assay for use in biosafety level 2 laboratories.

View Article and Find Full Text PDF